BTAIVSGNPX• 6 Months (Normalized)
BTAI vs GNPX (BioXcel Therapeutics Inc. vs Genprex Inc.)
Showing Closing Date Range from Mar, 19 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.04
-97.21%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
GNPX Performance $3.31
-92.16%
Genprex Inc.
Normalized Baseline0.00%
Alpha Spread Margin GNPX LEADS
-5.05%
GNPX outperforming by 5.05%
BTAIGNPX
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI GNPX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | BTAI Price | BTAI Gain (%) | GNPX Price | GNPX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $0.04 | -97.21% | $3.31 | -92.16% | -5.05% |
| Sep 14, 2026 | $0.05 | -97.18% | $3.45 | -91.83% | -5.35% |
| Sep 11, 2026 | $0.05 | -96.81% | $3.35 | -92.07% | -4.74% |
| Sep 10, 2026 | $0.05 | -96.88% | $3.35 | -92.07% | -4.81% |
| Sep 09, 2026 | $0.05 | -97.06% | $3.43 | -91.88% | -5.18% |
| Sep 08, 2026 | $0.04 | -97.31% | $3.54 | -91.62% | -5.69% |
| Sep 04, 2026 | $0.07 | -95.38% | $3.50 | -91.71% | -3.67% |
| Sep 03, 2026 | $0.12 | -92.63% | $3.43 | -91.89% | -0.74% |
| Sep 02, 2026 | $0.11 | -93.31% | $3.51 | -91.69% | -1.62% |
| Sep 01, 2026 | $0.14 | -91.44% | $3.55 | -91.60% | +0.16% |
| Aug 31, 2026 | $0.16 | -89.81% | $3.71 | -91.22% | +1.41% |
| Aug 28, 2026 | $0.18 | -88.69% | $3.67 | -91.31% | +2.62% |
| Aug 27, 2026 | $0.72 | -55.06% | $3.61 | -91.45% | +36.39% |
| Aug 26, 2026 | $0.78 | -51.25% | $3.97 | -90.60% | +39.35% |
| Aug 25, 2026 | $0.74 | -53.63% | $4.00 | -90.53% | +36.90% |
Page 1 of 9